Relationship: Strokes and EPA (eicosapentaenoic acid)

Evidence supporting the use of: EPA (eicosapentaenoic acid)
For the health condition: Strokes

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis
Other ingredients for this health condition
Other health conditions supported by this ingredient
Products containing this ingredient

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid found in marine oils, often studied for its potential cardiovascular benefits, including the prevention of stroke. Scientific interest in EPA and stroke prevention originates from observations that populations consuming diets high in fish oil have lower rates of cardiovascular events, including stroke. Mechanistically, EPA is thought to exert anti-inflammatory, antithrombotic, and lipid-lowering effects, all of which could theoretically reduce stroke risk.

Clinical evidence, however, is mixed and somewhat limited. Several large randomized controlled trials (RCTs) have examined the effect of omega-3 supplementation (including EPA) on stroke incidence. Meta-analyses show a modest reduction in cardiovascular events, but the effect on stroke prevention specifically is less clear, with some studies finding no significant reduction and others suggesting a small benefit. For example, the JELIS trial (using EPA alone) reported a reduction in major coronary events but did not find a statistically significant decrease in stroke rates. Other studies using EPA/DHA combinations have produced inconsistent results.

EPA is not typically used as a treatment for acute stroke but is promoted more for primary or secondary prevention. Major guideline organizations recognize some cardiovascular benefits of fish oil but do not universally recommend it specifically for stroke prevention due to insufficient evidence. Therefore, while there is a scientific rationale for EPA’s use and some supporting data, the evidence is not robust, and guidelines remain cautious.

More about EPA (eicosapentaenoic acid)
More about Strokes

Products containing EPA (eicosapentaenoic acid)

Health Concerns

Brands

Evidence supporting the use of: EPA (eicosapentaenoic acid)
For the health condition: Strokes

Table of Contents

Synopsis

Other ingredients used for Strokes

Other health conditions supported by EPA (eicosapentaenoic acid)

Products containing EPA (eicosapentaenoic acid)

Health Concerns

Brands

Evidence supporting the use of: EPA (eicosapentaenoic acid)For the health condition: Strokes

Table of Contents

Synopsis

Other ingredients used for Strokes

Other health conditions supported by EPA (eicosapentaenoic acid)

Products containing EPA (eicosapentaenoic acid)

Evidence supporting the use of: EPA (eicosapentaenoic acid)
For the health condition: Strokes